Hikma Pharmaceuticals PLC (HIK.L)
GBp 1921.0
(-0.05%)
GBp 1921.0
(-0.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 986 Million USD | -2.67% |
| 2022 | 1.01 Billion USD | 141.19% |
| 2021 | 420 Million USD | -31.03% |
| 2020 | 609 Million USD | 150.62% |
| 2019 | 243 Million USD | -32.69% |
| 2018 | 361 Million USD | -34.36% |
| 2017 | 550 Million USD | -21.99% |
| 2016 | 705 Million USD | 302.86% |
| 2015 | 175 Million USD | -37.94% |
| 2014 | 282 Million USD | 2.92% |
| 2013 | 274 Million USD | -32.88% |
| 2012 | 408.22 Million USD | -3.83% |
| 2011 | 424.46 Million USD | 305.39% |
| 2010 | 104.7 Million USD | -12.21% |
| 2009 | 119.27 Million USD | -30.54% |
| 2008 | 171.7 Million USD | -44.04% |
| 2007 | 306.81 Million USD | 1329.54% |
| 2006 | -24.95 Million USD | 71.3% |
| 2005 | -86.93 Million USD | -502.53% |
| 2004 | 21.59 Million USD | 449.18% |
| 2003 | -6.18 Million USD | -159.23% |
| 2002 | 10.44 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 987 Million USD | 0.0% |
| 2023 Q2 | 1.04 Billion USD | 0.0% |
| 2023 FY | 986 Million USD | -2.67% |
| 2023 Q4 | 986 Million USD | 0.0% |
| 2022 Q4 | 1.01 Billion USD | 0.0% |
| 2022 FY | 1.01 Billion USD | 141.19% |
| 2022 Q2 | 1.18 Billion USD | 0.0% |
| 2021 FY | 420 Million USD | -31.03% |
| 2021 Q2 | 610 Million USD | 0.0% |
| 2021 Q4 | 420 Million USD | 0.0% |
| 2020 Q2 | 514 Million USD | 0.0% |
| 2020 FY | 609 Million USD | 150.62% |
| 2020 Q4 | 609 Million USD | 0.0% |
| 2019 Q4 | 243 Million USD | 0.0% |
| 2019 Q2 | 373 Million USD | 0.0% |
| 2019 FY | 243 Million USD | -32.69% |
| 2018 Q2 | 501 Million USD | 0.0% |
| 2018 FY | 361 Million USD | -34.36% |
| 2018 Q4 | 361 Million USD | 0.0% |
| 2017 Q2 | 636 Million USD | 0.0% |
| 2017 FY | 550 Million USD | -21.99% |
| 2017 Q4 | 550 Million USD | 0.0% |
| 2016 Q4 | 705 Million USD | 0.0% |
| 2016 FY | 705 Million USD | 302.86% |
| 2016 Q2 | 825 Million USD | 0.0% |
| 2015 FY | 175 Million USD | -37.94% |
| 2015 Q2 | 288 Million USD | 0.0% |
| 2015 Q4 | 175 Million USD | 0.0% |
| 2014 Q2 | 182 Million USD | 0.0% |
| 2014 Q4 | 282 Million USD | 0.0% |
| 2014 FY | 282 Million USD | 2.92% |
| 2013 Q4 | 274 Million USD | 0.0% |
| 2013 Q2 | 362.34 Million USD | 0.0% |
| 2013 FY | 274 Million USD | -32.88% |
| 2012 Q4 | 408.22 Million USD | 300.0% |
| 2012 Q3 | 102.05 Million USD | -78.72% |
| 2012 Q2 | 479.63 Million USD | 369.97% |
| 2012 Q1 | 102.05 Million USD | -75.81% |
| 2012 FY | 408.22 Million USD | -3.83% |
| 2011 Q1 | 105.46 Million USD | 4.29% |
| 2011 Q3 | 105.46 Million USD | -67.57% |
| 2011 FY | 424.46 Million USD | 305.39% |
| 2011 Q4 | 421.87 Million USD | 300.0% |
| 2011 Q2 | 325.21 Million USD | 208.35% |
| 2010 Q4 | 101.13 Million USD | 300.0% |
| 2010 Q2 | 130.67 Million USD | 416.83% |
| 2010 Q1 | 25.28 Million USD | -78.38% |
| 2010 FY | 104.7 Million USD | -12.21% |
| 2010 Q3 | 25.28 Million USD | -80.65% |
| 2009 Q3 | 29.23 Million USD | -82.33% |
| 2009 FY | 119.27 Million USD | -30.54% |
| 2009 Q4 | 116.93 Million USD | 300.0% |
| 2009 Q2 | 165.43 Million USD | 465.87% |
| 2009 Q1 | 29.23 Million USD | -82.89% |
| 2008 Q4 | 170.88 Million USD | 300.0% |
| 2008 Q1 | 42.72 Million USD | -86.08% |
| 2008 Q2 | 198.33 Million USD | 364.24% |
| 2008 Q3 | 42.72 Million USD | -78.46% |
| 2008 FY | 171.7 Million USD | -44.04% |
| 2007 Q4 | 306.81 Million USD | 300.0% |
| 2007 Q1 | 76.7 Million USD | 407.37% |
| 2007 FY | 306.81 Million USD | 1329.54% |
| 2007 Q2 | 74.75 Million USD | -2.54% |
| 2007 Q3 | 76.7 Million USD | 2.6% |
| 2006 FY | -24.95 Million USD | 71.3% |
| 2006 Q1 | -6.23 Million USD | 92.82% |
| 2006 Q2 | -69.09 Million USD | -1007.48% |
| 2006 Q3 | -6.23 Million USD | 90.97% |
| 2006 Q4 | -24.95 Million USD | -300.0% |
| 2005 Q3 | -21.73 Million USD | -167.36% |
| 2005 Q1 | -21.73 Million USD | -276.91% |
| 2005 FY | -86.93 Million USD | -502.53% |
| 2005 Q4 | -86.93 Million USD | -300.0% |
| 2005 Q2 | 32.26 Million USD | 248.45% |
| 2004 FY | 21.59 Million USD | 449.18% |
| 2004 Q4 | 12.28 Million USD | 0.0% |
| 2004 Q3 | 12.28 Million USD | -0.0% |
| 2004 Q1 | 12.28 Million USD | 894.49% |
| 2004 Q2 | 12.28 Million USD | 0.0% |
| 2003 Q2 | -1.54 Million USD | 0.0% |
| 2003 FY | -6.18 Million USD | -159.23% |
| 2003 Q4 | -1.54 Million USD | 0.0% |
| 2003 Q1 | -1.54 Million USD | -159.23% |
| 2003 Q3 | -1.54 Million USD | 0.0% |
| 2002 Q1 | 2.61 Million USD | 0.0% |
| 2002 Q3 | 2.61 Million USD | 0.0% |
| 2002 Q4 | 2.61 Million USD | 0.0% |
| 2002 Q2 | 2.61 Million USD | 0.0% |
| 2002 FY | 10.44 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|